These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 11267938)
1. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung. Xue Q; Sano T; Kashiwabara K; Oyama T; Nakajima T Jpn J Cancer Res; 2001 Mar; 92(3):285-92. PubMed ID: 11267938 [TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung. Xue Q; Sano T; Kashiwabara K; Saito M; Oyama T; Nakajima T Pathol Int; 2002 Feb; 52(2):103-9. PubMed ID: 11940214 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas. Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692 [TBL] [Abstract][Full Text] [Related]
4. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Gorgoulis VG; Zacharatos P; Kotsinas A; Liloglou T; Kyroudi A; Veslemes M; Rassidakis A; Halazonetis TD; Field JK; Kittas C Am J Pathol; 1998 Dec; 153(6):1749-65. PubMed ID: 9846966 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma. Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984 [TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678 [TBL] [Abstract][Full Text] [Related]
7. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue. Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas. Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391 [TBL] [Abstract][Full Text] [Related]
9. Combined analysis of p53 and RB pathways in epithelial ovarian cancer. Hashiguchi Y; Tsuda H; Yamamoto K; Inoue T; Ishiko O; Ogita S Hum Pathol; 2001 Sep; 32(9):988-96. PubMed ID: 11567230 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Sano T; Masuda N; Oyama T; Nakajima T Pathol Int; 2002; 52(5-6):375-83. PubMed ID: 12100520 [TBL] [Abstract][Full Text] [Related]
12. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866 [TBL] [Abstract][Full Text] [Related]
13. p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years. Regezi JA; Dekker NP; McMillan A; Ramirez-Amador V; Meneses-Garcia A; Ruiz-Godoy Rivera LM; Chrysomali E; Ng IO Oral Oncol; 1999 Jul; 35(4):379-83. PubMed ID: 10645402 [TBL] [Abstract][Full Text] [Related]
14. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index. Ng IO; Lam KY; Ng M; Regezi JA Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312 [TBL] [Abstract][Full Text] [Related]
15. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer. Mathew R; Arora S; Khanna R; Mathur M; Shukla NK; Ralhan R Eur J Cancer; 2002 Apr; 38(6):832-41. PubMed ID: 11937319 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders. Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. Saito T; Nakajima T; Mogi K J Oral Pathol Med; 1999 May; 28(5):226-32. PubMed ID: 10226946 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of the p53, p21/Waf-1, Rb, p16 and Ki67 proteins in multiple myeloma. Kanavaros P; Stefanaki K; Vlachonikolis J; Papalazarou D; Rontogianni D; Arvanitis D; Antonakopoulos G; Gorgoulis V; Bai M; Agnantis NJ Anticancer Res; 2000; 20(6B):4619-25. PubMed ID: 11205312 [TBL] [Abstract][Full Text] [Related]
19. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway. Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130 [TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]